Read More Pharma Industry News Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9bn in strategic expansion In a major development in the biotechnology industry, Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Alpine Immune Sciences, Inc.… byPallavi MadhirajuApril 11, 2024